Related Experiment Videos
Diagnosis and management of folate deficiency in low birthweight infants
Insights
Peripheral blood morphology reliably diagnoses folate deficiency in preterm infants. A daily folic acid dose of 100-200 micrograms ensures optimal hematological response and replenishes tissue stores.
Area of Science:
- Neonatal Medicine
- Hematology
- Nutritional Science
Background:
- Preterm infants, especially those with low birth weight (≤2.0 kg), are susceptible to nutritional deficiencies.
- Folate deficiency can lead to significant health issues in neonates, impacting hematopoiesis.
- Accurate and timely diagnosis of folate deficiency is crucial for appropriate intervention in this vulnerable population.
Observation:
- Morphological changes in peripheral blood smears were identified as a reliable indicator of folate deficiency in preterm infants.
- Deficiency was more prevalent in light-for-dates infants and the smaller twin.
- Clinical status, hemoglobin levels, and erythrocyte folate were unreliable diagnostic markers in very young preterm infants.
Findings:
- Abnormal peripheral blood morphology accurately diagnosed significant folate deficiency in 14 out of 37 preterm infants.
- Response to folic acid administration confirmed the diagnosis.
- Optimal hematological response and tissue folate repletion in preterm infants require 100-200 micrograms of folic acid daily, administered orally or intramuscularly.
Implications:
- Peripheral blood morphology offers a convenient and reliable method for diagnosing folate deficiency in preterm neonates.
- A daily folic acid dosage of 100-200 micrograms is recommended for therapeutic trials when diagnosis is uncertain and for replenishing tissue stores.
- This study highlights the importance of monitoring folate status in low birth weight and light-for-dates preterm infants.
Abstract:
Significant folate deficiency in 14 out of 37 preterm infants of birthweights 2.0 kg or less was found to be reliably and most conveniently diagnosed by abnormal morphological changes in peripheral blood and confirmed by the response to folic acid. Deficiency appeared to be more common in light-for-dates infants including the smaller of twins. Neither the clinical status nor the levels of haemoglobin or erythrocyte folate was a reliable guide to the presence of megaloblastic erythropoiesis in the very young preterm infant. 100-200 microgram folic acid a day, orally or IM, may be required to ensure an optimal haematological response, and this would be appropriate for therapeutic trial if the diagnosis is in doubt. This amount would also replenish tissue folate stores; larger doses are likely to exceed the requirements of small infants.